Nengyi Ni

机构：National University of Singapore, Shandong Tumor Hospital, Shandong First Medical University · ORCID：0000-0002-8904-0695

发表论文 32 篇 · 总被引 586 次 · h-index 11

代表论文

• Engineering tumoral vascular leakiness with gold nanoparticles (2023 · Nature Communications · 被引 91)
• Biodegradable two-dimensional nanomaterials for cancer theranostics (2022 · Coordination Chemistry Reviews · 被引 78)
• Inducible endothelial leakiness in nanotherapeutic applications (2022 · Biomaterials · 被引 55)
• Endothelial leakiness elicited by amyloid protein aggregation (2024 · Nature Communications · 被引 43)
• Disturbing cytoskeleton by engineered nanomaterials for enhanced cancer therapeutics (2023 · Bioactive Materials · 被引 42)
• CCR2-overexpressing biomimetic carrier-free nanoplatform for enhanced cascade ferroptosis tumor therapy (2023 · Acta Biomaterialia · 被引 21)